NeOnc Technologies (NTHI) will be featured on Health Uncensored hosted by Dr. Drew Pinsky. The episode is scheduled to air on the Lifetime Network, available to approximately 63 million television households in the United States, on September 25th, premiering nationwide at 8:00 a.m. ET/PT. The show averages over 500,000 viewers per episode, underscoring the significant national exposure of this feature. Amir Heshmatpour, Executive Chairman and President of NeOnc Technologies, and Dr. Thomas Chen, CEO and Chief Medical Officer, will sit down with Dr. Drew to explain NeOnc’s platform technology. Viewers will also hear directly from a patient whose brain cancer is in remission, providing a firsthand account of how NeOnc’s drug candidates are designed to overcome the body’s Blood-Brain Barrier and thus have the potential to change lives. “The Blood-Brain Barrier has long been a formidable obstacle in treating brain cancer, leaving many patients with limited options. We believe our NEO platform technology represents a paradigm shift, designed to carry potent therapies directly across this barrier to the tumor site,” said Heshmatpour. “This national platform is a timely opportunity to share our vision, highlight a patient’s incredible journey of recovery, and update the public on the significant momentum we are building as we advance our clinical programs toward key data readouts.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTHI:
- NeOnc Technologies Advances to Phase II Brain Cancer Trial
- NeOnc receives FDA authorization to proceed with Phase II trial of NEO212
- NeOnc closes strategic acquisition of advanced AI, 3D bioprinting IP
- NeOnc Completes Acquisition and Board Reshuffle
- NeOnc Technologies reports Q2 EPS (30c) vs (27c) last year